The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America - 1st Edition - ISBN: 9780323532358, 9780323532365

The Treatment of Myeloid Malignancies with Kinase Inhibitors, An Issue of Hematology/Oncology Clinics of North America, Volume 31-4

1st Edition

Authors: Ann Mullally
eBook ISBN: 9780323532365
Hardcover ISBN: 9780323532358
Imprint: Elsevier
Published Date: 11th July 2017
Info/Buy

Secure Checkout

Personal information is secured with SSL technology.

Free Shipping

Free global shipping
No minimum order.

Description

This issue of Hematology/Oncology Clinics will focus on The Treatment of Myeloid Malignancies with Kinase Inhibitors. Articles will focus on: Targeting aberrant signaling in myeloid malignancies: promise versus reality; The development and use of imatinib for the treatment of chronic myelogenous leukemia; Mechanisms of resistance to ABL kinase inhibition in CML and the development of next generation ABL kinase inhibitors; Tyrosine kinase inhibitors in the treatment of systemic mastocytosis and hypereosinophilic syndrome; The development and use of JAK2 inhibitors for the treatment of myeloproliferative neoplasms (MPN); Mechanisms of resistance to JAK2 inhibitors in MPN; Kinase inhibitor screening in myeloid malignancies; and more!


Details

Copyright:
© Elsevier 2017
Published:
Imprint:
Elsevier
eBook ISBN:
9780323532365
Hardcover ISBN:
9780323532358

About the Authors

Ann Mullally Author

Affiliations and Expertise

Dana-Farber/Brigham and Women's Cancer Center